Free shipping on all orders over $ 500

Tucatinib

Cat. No. M10038

All AbMole products are for research use only, cannot be used for human consumption.

Tucatinib Structure
Synonym:

Irbinitinib; ARRY-380; ONT-380

Size Price Availability Quantity
10mM*1mL in DMSO USD 70 In stock
1mg USD 30 In stock
5mg USD 50 In stock
10mg USD 85 In stock
25mg USD 150 In stock
50mg USD 225 In stock
200mg USD 700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tucatinib, also known as Irbinitinib and ONT-380, is an orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (HER2). Irbinitinib selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells.

Chemical Information
Molecular Weight 480.52
Formula C26H24N8O2
CAS Number 937263-43-9
Solubility (25°C) DMSO 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Nancy U Lin, et al. J Clin Oncol. Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

[2] Anita Kulukian, et al. Mol Cancer Ther. Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models

[3] Rashmi K Murthy, et al. N Engl J Med. Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

[4] Cancer Discov. Tucatinib Impresses in Breast Cancer

Related EGFR/HER2 Products
AEE788

AEE788 (NVP-AEE788) is a novel multitargeted HER 1/2 and VEGFR 1/2 receptor family tyrosine kinases inhibitor with IC50 of 2, 6, 77, 59 nM for EGFR, ErbB2, KDR, and Flt-1.

Sapitinib (AZD8931)

AZD8931 (Sapitinib) is an equipotent, reversible inhibitor of Signaling by EGFR, ERBB2 (HER2), and ERBB3 with IC50 of 4, 3, 4 nM respectively.

Afatinib

Afatinib (BIBW 2992) is a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor.

CP-724714

CP-724714 is a potent and selective orally active HER-2 tyrosine kinase inhibitor, IC50 = 3 nM.

Erlotinib Hydrochloride

Erlotinib is an inhibitor of human EGFR tyrosine kinase (IC50 = 2 nM) and decreases EGFR autophosphorylation in tumor cells (IC50 = 20 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: Tucatinib, Irbinitinib; ARRY-380; ONT-380 supplier, EGFR/HER2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.